Unverified50% confidenceFactExact time

Alzheimer's disease blood tests indirectly reflect pathological changes in the brain by measuring biomarkers such as plasma p-tau protein and amyloid ratios.

1

Sources

50%

Confidence

Long-term

Relevance

8/30/2026

First Seen

Sources

FDA Approves Blood Test for Alzheimer's Disease: A Major Step Toward Lowering the Barrier to Early Screening

Related Entities

p-tau217concept 阿尔茨海默病血液检测product

Related Claims

UnverifiedThe FDA approved a blood test for use in the auxiliary assessment of Alzheimer's disease.73% similar Unverified该研究揭示的是相关性而非因果性，不意味着开出租车能预防阿尔茨海默病58% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/823837

API

curl https://kongchang.com/api/v1/knowledge/claims/823837

MCP

get_claim(id=823837)